PFC
DPLO

Phocas Financial Corp’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Phocas Financial Corp’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-200,649
Closed -$3.9M – 366
2018
Q3 		$3.9M Sell
200,649
-3,641
-2% -$77.5K 0.34% 115
2018
Q2 		$5.22M Sell
204,290
-423,709
-67% -$9.88M 0.45% 102
2018
Q1 		$12.7M Sell
627,999
-35,188
-5% -$821K 1.14% 25
2017
Q4 		$13.3M Buy
663,187
+390,168
+143% +$7.67M 1.12% 23
2017
Q3 		$6M Buy
+273,019
New +$4.62M 0.5% 90

Other funds holding DPLO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Phocas Financial Corp's DPLO Position: Q4 2018 in Review

Phocas Financial Corp sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q4 2018, closing a stake of 200,649 shares — an estimated $3.9M sold.

Phocas Financial Corp first reported a position in DPLO in Q3 2017 and held it in 5 quarters. The position peaked at $13.3M in Q4 2017. 157 funds tracked by Wall St. Rank hold DPLO as of Q4 2018.

  • Phocas Financial Corp reported no remaining DIPLOMAT PHARMACY, INC. position as of Q4 2018 after selling out during the quarter.
  • Phocas Financial Corp sold 200,649 DIPLOMAT PHARMACY, INC. shares in Q4 2018, an estimated $3.9M.
  • Phocas Financial Corp first reported a position in DIPLOMAT PHARMACY, INC. in Q3 2017 and held it in 5 quarters.
  • Phocas Financial Corp's DIPLOMAT PHARMACY, INC. position peaked at $13.3M in Q4 2017.
  • 157 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q4 2018.

Based on Phocas Financial Corp's 13F filing for Q4 2018, filed 15 Feb 2019.